Country

Timeline of privileges regarding the commercialization and use of knowledge. Part 2: 1980 to 1999

Draft
This is work in progress, and is part of a larger project on timelines. This particular timeline is unfinished, and may contain errors.

Timeline of privileged regarding the commercialization and use of knowledge

Country Menu

keionline.info - Country Menu

Kazakhstan

Thailand

India

Brazil 

The HELP Committee and Eshoo/Barton language on biosimilars (biogenerics)

Here are links to the language adopted in the HELP committee, and the most recent version of the Eshoo/Barton proposal on biosimilars. In many areas, the Eshoo/Barton language is worse than the already bad bill adopted in the HELP committee.

Syngenta AG on patent pools and prizes

On July 14, 2009, at the WIPO Conference on Intellectual Property and Public Policy Issues, Michael Kock (Global Head IP Seeds and Biotechnology at Syngenta International AG) underscored that today’s global challenges can only dealt with in an efficient manner by creating innovation networks which included the reward of substantial amounts of money to solve technical challenges and problems.

Sweden, acting badly

I’m not sure who has been sharing this on the list, but the very worst country in the negotiations, among the 190+ members of the WHO, is, without a doubt, Sweden. Sweden has been making it very difficult for Europe to take reasonable positions in the negotiations, and Sweden is consistently taking the most extreme positions in the negotiations among the European countries, and competing with Mexico for the most anti-consumer views in the room.

IGWG2 awards

The IGWG Negotiations are coming to the end, and although it is not clear what the package the negotiators will deliver is, enough of the process has been seen to rate the performances of some of the actors.

Mexico’s proposed deletion of consumer rights in the IGWG Text

Tomorrow morning (Friday the 9th), the IGWG finally takes up Element 5, the intellectual property text. These are the deletions to the text being requested by Mexico.

———-
ELEMENT 3

This would include:
building innovative capacity in science and technology and traditional medicine/genetic resources, in agreement with the legislation existing in the Parties on this issues;
rational health-orientated intellectual property management. (Mexico suggest delete)

Syndicate content